Fauchald P, Noddeland H, Norseth J
Acta Med Scand. 1985;217(1):127-31. doi: 10.1111/j.0954-6820.1985.tb01645.x.
Plasma volume, plasma colloid osmotic pressure, creatinine clearance and sodium excretion were measured before and after ultrafiltration treatment in six patients with diuretic-resistant nephrotic syndrome. The mean total ultrafiltrate volume in two sessions on two successive days was 7460 ml, the mean ultrafiltration rate was 22.0 ml/min and the calculated plasma refilling rate was 19.9 ml/min. Plasma volume and creatinine clearance were unchanged and sodium excretion was reduced after treatment. A short-lasting drop in blood pressure was seen in 3 of the 12 treatment sessions. No other complications were noted. Ultrafiltration is a safe and useful alternative in the treatment of the few patients with massive oedema due to nephrotic syndrome not responding to conventional therapy.
对6例利尿剂抵抗型肾病综合征患者在超滤治疗前后测量了血浆容量、血浆胶体渗透压、肌酐清除率和钠排泄量。连续两天进行的两个疗程的平均总超滤量为7460毫升,平均超滤率为22.0毫升/分钟,计算出的血浆再充盈率为19.9毫升/分钟。治疗后血浆容量和肌酐清除率未变,钠排泄量减少。12个治疗疗程中有3个出现了短暂的血压下降。未发现其他并发症。对于少数因肾病综合征导致大量水肿且对传统治疗无反应的患者,超滤是一种安全有效的替代治疗方法。